BAKER DOUGLAS P
Insider CIK 1028775 · OPRX Chief Financial Officer · APNT Former CFO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-10-05 | 2021-10-05 | 10,000 | $7.51 | $75.1K | 34,699 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-10-05 | 2021-10-05 | 10,000 | $82.35 | $823.5K | 34,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-10-05 | 2021-10-05 | 4,000 | $84.22 | $336.9K | 34,796 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-10-05 | 2021-10-05 | 10,000 | $7.51 | $75.1K | 44,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-09-28 | 2021-09-29 | 2,000 | $74.66 | $149.3K | 38,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-09-21 | 2021-09-22 | 4,000 | $70.59 | $282.4K | 40,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-09-14 | 2021-09-15 | 3,768 | $65.57 | $247.1K | 44,796 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-09-08 | 2021-09-09 | 10,000 | $7.51 | $75.1K | 44,699 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-09-08 | 2021-09-09 | 10,000 | $67.25 | $672.5K | 48,564 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-09-08 | 2021-09-09 | 10,000 | $7.51 | $75.1K | 58,564 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-09-07 | 2021-09-09 | 2,232 | $70.53 | $157.4K | 48,564 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-08-31 | 2021-09-02 | 4,000 | $66.62 | $266.5K | 50,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-08-24 | 2021-08-24 | 4,000 | $61.50 | $246.0K | 54,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-08-20 | 2021-08-24 | 5,000 | $58.45 | $292.3K | 58,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-08-17 | 2021-08-17 | 4,000 | $58.46 | $233.8K | 63,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-08-13 | 2021-08-17 | 5,000 | $63.27 | $316.4K | 67,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-08-10 | 2021-08-10 | 2,000 | $64.50 | $129.0K | 72,796 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-08-09 | 2021-08-10 | 10,000 | $7.51 | $75.1K | 54,699 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-08-09 | 2021-08-10 | 10,000 | $64.31 | $643.1K | 64,796 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-08-09 | 2021-08-10 | 10,000 | $7.51 | $75.1K | 74,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-08-03 | 2021-08-03 | 2,000 | $54.93 | $109.9K | 74,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-07-27 | 2021-07-28 | 3,000 | $52.58 | $157.7K | 76,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-07-20 | 2021-07-21 | 3,000 | $50.90 | $152.7K | 79,796 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-07-08 | 2021-07-09 | 13,435 | — | $0 | 64,699 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-07-08 | 2021-07-09 | 13,435 | $56.05 | $753.0K | 69,361 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-07-08 | 2021-07-09 | 13,435 | $2.46 | $33.1K | 82,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-06-28 | 2021-06-30 | 3,421 | $63.00 | $215.5K | 82,796 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-06-24 | 2021-06-25 | 4,000 | $60.00 | $240.0K | 86,217 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-06-07 | 2021-06-08 | 14,500 | — | $0 | 78,134 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-06-07 | 2021-06-08 | 14,500 | $2.46 | $35.7K | 90,217 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-06-07 | 2021-06-08 | 14,500 | $52.62 | $763.0K | 75,717 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-05-18 | 2021-05-19 | 14,500 | — | $0 | 92,634 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-05-18 | 2021-05-19 | 14,500 | $45.85 | $664.8K | 75,717 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-05-18 | 2021-05-19 | 14,500 | $2.46 | $35.7K | 90,217 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-01-29 | 2021-01-29 | 4,315 | $7.51 | $32.4K | 107,134 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-01-29 | 2021-01-29 | 4,315 | $7.51 | $32.4K | 90,217 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-01-29 | 2021-01-29 | 5,032 | $47.25 | $237.8K | 85,902 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-01-13 | 2021-01-15 | 5,000 | $7.51 | $37.5K | 96,993 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-01-13 | 2021-01-15 | 5,000 | $38.89 | $194.4K | 85,937 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-01-13 | 2021-01-15 | 5,000 | $7.51 | $37.5K | 90,937 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-01-07 | 2021-01-11 | 14,456 | — | $0 | 116,449 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-01-04 | 2021-01-05 | 4,000 | $7.51 | $30.0K | 101,993 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2021-01-04 | 2021-01-05 | 4,566 | $2.46 | $11.2K | 105,993 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-01-04 | 2021-01-05 | 4,566 | $2.46 | $11.2K | 86,937 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-01-04 | 2021-01-05 | 8,334 | $32.88 | $274.0K | 82,371 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2021-01-04 | 2021-01-05 | 4,000 | $7.51 | $30.0K | 90,937 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2020-11-12 | 2020-11-13 | 15,000 | $2.46 | $36.9K | 110,559 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2020-11-12 | 2020-11-13 | 15,000 | $2.46 | $36.9K | 90,705 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2020-11-11 | 2020-11-13 | 15,000 | $24.05 | $360.8K | 75,705 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2020-09-02 | 2020-09-04 | 10,000 | $2.46 | $24.6K | 125,559 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2020-09-02 | 2020-09-04 | 10,000 | $20.00 | $200.0K | 80,705 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2020-09-02 | 2020-09-04 | 10,000 | $2.46 | $24.6K | 90,705 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2020-08-14 | 2020-08-14 | 10,000 | $2.46 | $24.6K | 135,559 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2020-08-14 | 2020-08-14 | 10,000 | $2.46 | $24.6K | 110,671 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2020-08-13 | 2020-08-14 | 10,000 | $18.00 | $180.0K | 100,671 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2020-08-07 | 2020-08-07 | 10,000 | $2.46 | $24.6K | 145,559 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2020-08-07 | 2020-08-07 | 10,000 | $2.46 | $24.6K | 110,671 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2020-08-06 | 2020-08-07 | 10,000 | $17.01 | $170.1K | 100,671 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2020-07-17 | 2020-07-17 | 8,000 | $2.46 | $19.7K | 155,559 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2020-07-17 | 2020-07-17 | 8,000 | $2.46 | $19.7K | 90,671 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2020-07-16 | 2020-07-17 | 6,667 | $15.00 | $100.0K | 82,671 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2020-06-03 | 2020-06-04 | 23,302 | — | $0 | 163,559 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2020-06-03 | 2020-06-04 | 17,421 | $3.15 | $54.9K | 89,338 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2020-03-11 | 2020-03-13 | 63,558 | — | $0 | 186,861 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2020-01-29 | 2020-01-30 | 5,032 | $3.15 | $15.9K | 123,303 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2020-01-29 | 2020-01-30 | 5,032 | $3.15 | $15.9K | 71,917 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2019-11-07 | 2019-11-07 | 5,000 | $3.15 | $15.8K | 128,335 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2019-11-07 | 2019-11-07 | 5,000 | $3.15 | $15.8K | 66,885 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2019-05-10 | 2019-05-13 | 8,334 | $3.15 | $26.3K | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2019-05-10 | 2019-05-13 | 8,334 | $3.15 | $26.3K | 61,885 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2019-05-02 | 2019-05-03 | 5,000 | $3.15 | $15.8K | 8,334 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2019-05-02 | 2019-05-03 | 5,000 | $3.15 | $15.8K | 53,551 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2019-03-27 | 2019-03-29 | 16,667 | — | $0 | 48,551 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2019-02-25 | 2019-02-26 | 10,000 | — | $0 | 26,667 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2019-01-02 | 2019-01-03 | 5,000 | $3.15 | $15.8K | 13,334 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2019-01-02 | 2019-01-03 | 5,000 | $3.15 | $15.8K | 31,884 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2018-08-10 | 2018-08-10 | 15,000 | $3.15 | $47.3K | 151,669 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2018-08-10 | 2018-08-10 | 1,000 | $12.05 | $12.1K | 11,884 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2018-08-10 | 2018-08-10 | 1,000 | $12.01 | $12.0K | 12,884 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2018-08-10 | 2018-08-10 | 15,000 | $3.15 | $47.3K | 26,884 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2018-08-10 | 2018-08-10 | 2,000 | $12.00 | $24.0K | 13,884 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2018-08-09 | 2018-08-10 | 784 | $12.00 | $9.4K | 15,884 | SEC↗ |
| OPRX OptimizeRx Corp | C Conversion deriv | 2018-03-27 | 2019-03-29 | 16,667 | — | $0 | 10,000 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2018-02-01 | 2018-02-02 | 50,000 | — | $0 | 550,000 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2017-05-11 | 2017-05-15 | 10,000 | $0.77 | $7.7K | 50,000 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2017-03-31 | 2017-04-04 | 200,000 | — | $0 | 400,000 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2017-03-31 | 2017-04-04 | 100,000 | — | $0 | 500,000 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2016-11-14 | 2016-11-14 | 10,000 | $0.85 | $8.5K | 40,000 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2016-06-07 | 2016-06-08 | 10,000 | $1.05 | $10.5K | 30,000 | SEC↗ |
| OPRX OptimizeRx Corp | J Other deriv | 2015-06-24 | 2015-06-26 | 0 | — | $0 | 100,000 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2015-05-24 | 2015-06-26 | 100,000 | — | $0 | 200,000 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2014-11-17 | 2014-11-17 | 10,000 | $0.88 | $8.8K | 20,000 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2014-06-05 | 2014-06-05 | 10,000 | $1.50 | $15.0K | 10,000 | SEC↗ |
| APNT Applied Nanotech Holdings, | A Award deriv | 2012-04-30 | 2012-05-02 | 12,500 | — | $0 | 1,249,100 | SEC↗ |
| APNT Applied Nanotech Holdings, | A Award deriv | 2012-02-02 | 2012-02-02 | 12,500 | — | $0 | 1,236,600 | SEC↗ |